替罗非班治疗缺血性脑血管病的研究进展

【摘要】 急性缺血性脑血管病严重危害人类的健康，抗血小板治疗是急性缺血性脑血管病极其重要的治疗方法，替罗非班是新型抗血小板药物之一。本文对目前国内外替罗非班治疗缺血性脑血管病的研究进行总结，为缺血性脑血管病抗血小板治疗提供新思路。

【关键词】 替罗非班 缺血性脑血管病 综述

Research Progress of Tirofiban in the Treatment of Ischemic Cerebrovascular Diseases/LI Wenbin， LIU Zheng， LI Zhigang. //Medical Innovation of China， 2023， 20（24）： -188

[Abstract] Acute ischemic cerebrovascular disease is seriously harmful to human health. Antiplatelet therapy is a very important treatment for acute ischemic cerebrovascular disease. Tirofiban is one of the new antiplatelet drugs. This article summarizes the current research on Tirofiban in the treatment of ischemic cerebrovascular disease at home and abroad， in order to provide a new idea for antiplatelet therapy of ischemic cerebrovascular disease.

[Key words] Tirofiban Ischemic cerebrovascular disease Review

First-author's address： The First Clinical Medical School， Gannan Medical University， Ganzhou 314000， China

doi：10.3969/j.issn.1674-4985.2023.24.043

脑卒中是全球第二大致死原因，也是第三大致残原因。（剩余13985字）